SCHEMBL4239069

SCHEMBL4239069

CC(C)(C)OC(=O)N1Cc2ccc(NC3CCN(C(=O)OCc4ccccc4)CC3)cc2C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
TMEM97 Q5BJF2 4/20 0.52
SIGMAR1 Q99720 4/20 0.52
NPC1 O15118 4/20 0.52
RAB9A P51151 4/20 0.52
HRH1 P35367 3/20 0.52
HRH3 Q9Y5N1 3/20 0.52
HTR1A P08908 2/20 0.52
ADRA2C P18825 2/20 0.52
HRH2 P25021 2/20 0.52
HTT P42858 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
MAPT P10636 1/20 0.52
MAPK1 P28482 1/20 0.52
ADRA2A P08913 1/20 0.52
ADRA2B P18089 1/20 0.52
DRD1 P21728 1/20 0.52
HTR1B P28222 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19954031 0.83 ALDH1A1 (0.61) ALDH1A1NPC1RAB9AHTTL3MBTL1
SCHEMBL22632810 0.83 ALDH1A1 (0.58) ALDH1A1NPC1RAB9AHTTL3MBTL1
SCHEMBL12853755 0.82 ALDH1A1 (0.63) ALDH1A1NPC1RAB9AHTTL3MBTL1
SCHEMBL7043474 0.82 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AHTTL3MBTL1
SCHEMBL30449380 0.82 TMEM97 (0.77) TMEM97SIGMAR1HRH1HRH3HTR1A
SCHEMBL17262543 0.82 ALDH1A1 (0.54) ALDH1A1NPC1RAB9AHTTL3MBTL1
SCHEMBL28699149 0.82 TMEM97 (0.77) TMEM97SIGMAR1HRH1HRH3HTR1A
SCHEMBL23673943 0.81 TMEM97 (0.56) TMEM97SIGMAR1HRH1HRH3HTR1A
SCHEMBL22529537 0.81 TMEM97 (0.56) TMEM97SIGMAR1HRH1HRH3HTR1A
SCHEMBL29974284 0.81 TMEM97 (0.56) TMEM97SIGMAR1HRH1HRH3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491735-B2 Chemokine receptor binding compounds GENZYME CORPORATION (US) 2009-02-17 US disclosed
US-20050277670-A1 Chemokine receptor binding compounds ANORMED INC. 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277670-A1 Chemokine receptor binding compounds CCR5, CXCR3, CCL5 ALDH1A1 3358/4885TMEM97 620/4885SIGMAR1 890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.